ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.57
11.31
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
|
5.2B CNY |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
972.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.4B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
219B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.1B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.3B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
93.8B EUR |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
ZhuZhou QianJin Pharmaceutical Co Ltd
Glance View
Zhuzhou Qianjin Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Zhuzhou, Hunan and currently employs 4,975 full-time employees. The company went IPO on 2004-03-12. The firm's main products include tablets, granules, pills, hard capsules, syrups, herbs, vinum and gels, among others. The firm is also involved in the businesses of cultural entertainment, logistics and distribution, as well as the provision of hygienic products.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for ZhuZhou QianJin Pharmaceutical Co Ltd is 8.4%, which is below its 3-year median of 9.7%.
Over the last 3 years, ZhuZhou QianJin Pharmaceutical Co Ltd’s Operating Margin has decreased from 10.3% to 8.4%. During this period, it reached a low of 7.9% on Dec 31, 2024 and a high of 11% on Jun 30, 2024.